-
1.
公开(公告)号:EP4392431A1
公开(公告)日:2024-07-03
申请号:EP22793641.6
申请日:2022-09-29
发明人: DU, Nana , O'YANG, Counde , WANG, Hexiang , LI, Zhihong
IPC分类号: C07H19/10 , C07H19/207 , A61K31/7052 , A61P29/00 , A61P35/00 , A61P37/00
-
公开(公告)号:EP3728592B1
公开(公告)日:2024-05-29
申请号:EP18833230.8
申请日:2018-12-21
CPC分类号: C07H21/00 , C12N15/111 , C12N2310/31320130101 , C12N2310/31520130101 , C12N2310/323120130101 , C12N2310/34620130101 , C07F9/65586 , C07F9/6561 , C07F9/65616 , C07H1/02
-
3.
公开(公告)号:EP4303314A3
公开(公告)日:2024-04-17
申请号:EP23186456.2
申请日:2016-08-26
发明人: BERGMANN, Frank , SEIDEL, Christoph , TRANS, Andrew , GREMYACHINSKIY, Dimitry , KUCHELMEISTER, Hannes , HILLRINGHAUS, Lars
IPC分类号: C12Q1/6869 , C07H19/10 , C07H19/20
CPC分类号: C07H19/10 , C07H19/20 , C12Q1/6869
摘要: The present disclosure relates to compositions and methods based on polypeptide-tagged nucleotide, and the use of such polypeptide-tagged nucleotides in nanopore devices and methods.
-
公开(公告)号:EP4347857A1
公开(公告)日:2024-04-10
申请号:EP22747154.7
申请日:2022-05-19
-
公开(公告)号:EP4282482A3
公开(公告)日:2024-01-17
申请号:EP23197008.8
申请日:2008-03-26
IPC分类号: C07H19/10 , A61K31/7072 , A61P31/00
摘要: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure:
Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.-
公开(公告)号:EP4275690A3
公开(公告)日:2023-11-22
申请号:EP23191049.8
申请日:2019-11-11
发明人: SAWAMOTO, Hiroaki , KUMAGAI, Shinji , FURUKAWA, Hiroyuki , ARAKI, Tomo , UTSUGI, Masayuki , OBIKA, Satoshi
IPC分类号: C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , C07H21/04 , A61P43/00 , C12N15/10 , A61K31/712
摘要: The present invention provides a novel bridged artificial nucleic acid and an oligomer containing the same as a monomer. The present invention provides specifically a compound represented by general formula (I) (wherein each symbol is the same as defined in the specification) or salts thereof; as well as an oligonucleotide compound represented by general formula (I') (wherein each symbol is the same as defined in the specification) or salts thereof.
-
公开(公告)号:EP4028407B1
公开(公告)日:2023-08-16
申请号:EP20776287.3
申请日:2020-09-10
-
公开(公告)号:EP4092118A1
公开(公告)日:2022-11-23
申请号:EP21215936.2
申请日:2018-12-21
发明人: BLEICHER, Konrad , DUSCHMALÉ, Joerg , DUSCHMALÉ, Martina Brigitte , HANSEN, Henrik Frydenlund , KOCH, Troels , LI, Meiling , SCHAEUBLIN, Adrian , SHU, Xi , WU, Yong
摘要: The present invention relates to a compound of formula (II) or (IIb)
wherein X, Y, R x , R y , R 5 and Nu are as defined in the description and in the claims. The compound of formula (II) can be used in the manufacture of oligonucleotides.-
公开(公告)号:EP4052730A1
公开(公告)日:2022-09-07
申请号:EP20882572.9
申请日:2020-10-28
申请人: National University Corporation Tokai National Higher Education and Research System , YAMASA CORPORATION
发明人: UENO,Yoshihito
IPC分类号: A61K48/00 , C07H19/10 , C12N15/113 , A61K31/713
摘要: Provided is a nucleoside derivative represented by the following formula (1):
, or a salt thereof,
wherein R 1 represents an alkoxy group, a hydrogen atom or a halogen atom; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, or -P(=O) n R 5 R 6 in which n represents 0 or 1, R 5 and R 6 , which may be the same as or different from each other, each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an alkoxy group, a cyanoalkoxy group, an amino group, or a substituted amino group, provided that when n is 1, both R 5 and R 6 cannot be the hydrogen atom at the same time; R 3 represents -(CH 2 ) m NHR 7 in which m represents an integer of 1 to 6, R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group.-
公开(公告)号:EP4043471A1
公开(公告)日:2022-08-17
申请号:EP21218125.9
申请日:2018-12-05
申请人: Nucana PLC
IPC分类号: C07H19/10 , C07H19/20 , A61K31/7068 , A61K31/7076 , A61P35/00
摘要: The present invention relates to compounds comprising a salt of a diphosphate phosphoramidate of a nucleoside drug, e.g. clofarabine. The compounds are useful in the treatment of cancer, e.g. leukemia.
-
-
-
-
-
-
-
-
-